NVE Corporation (NVEC) Q2 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call shows promising signs of future growth with strong R&D results and expansion plans, especially in core markets. The company's focus on innovative products like wafer-level chip scale sensors and advanced magnetic switch sensors is expected to drive sales. While some responses were vague, the overall sentiment from the Q&A indicates optimism, particularly with upcoming growth drivers and industry recovery. The anticipation of significant cash flow savings and a strong pipeline further supports a positive outlook for stock price movement.
Key Financial Performance
Revenue Revenue increased 4% quarter-over-quarter sequentially and decreased 6% year-over-year. The year-over-year decrease was due to a 68% decrease in contract R&D revenue, partially offset by a 1% increase in product sales. Contract R&D was 3% of revenue. The year-over-year increase in product sales was due to a 21% increase in nondefense sales, partially offset by a 64% decrease in defense sales which can be volatile because of defense procurement cycles.
Gross Margin Gross margin decreased to 78% from 86% in the prior year quarter due to a less profitable product mix and strong distributor sales, which tend to have lower margins than direct sales.
Total Expenses Total expenses decreased 7% for the second quarter of fiscal 2026 compared to the second quarter of fiscal 2025 due to a 3% increase in R&D expense and a 23% decrease in SG&A. The increase in R&D was due to increased new product development. The decrease in SG&A was primarily due to the timing of sales and marketing activities and reassignment of some SG&A resources to manufacturing and new product development.
Tax Rate Tax rate increased to 20% for the second quarter of fiscal 2026 compared to 17% for the second quarter of fiscal 2025, primarily due to the noncash impact of tax law changes on certain tax deductions this fiscal year.
Net Income Net income for the second quarter of fiscal 2026 was $3.31 million or $0.68 per diluted share compared to $4.03 million or $0.83 per share for the prior year quarter. The decrease in net income for the quarter was primarily due to decreased revenue, lower margins and a higher tax rate compared to a year ago, partially offset by decreased expenses.
Profitability Metrics Operating margin was 58%, pretax margin was 65% and net margin was 52%.
Cash Flow from Operations Cash flow from operations was $7.98 million in the first 6 months of the fiscal year. Accounts receivable decreased $1.1 million, primarily due to the timing of customer payments. Prepaid expenses and other assets increased by $730,000 primarily due to an increase in accrued bond interest and a decrease in federal and state taxes due.
Fixed Asset Purchases Fixed asset purchases were $1.13 million for the first half of the fiscal year. Most of that was for a cluster of production equipment, which arrived in July. The equipment was successfully installed in the past quarter and deployment is expected to be completed by the end of this fiscal year.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Equipment and R&D: Installation of a new equipment cluster and expanded production area to increase capacity and capabilities, including wafer-level chip scale packaging for smaller and more precise parts.
New Products: Launched three new products: a rotation sensor for robotics and utility meters, a data coupler for motor control and energy conversion, and a wafer-level chip scale voltage regulator for harsh environments.
Medical Devices Market: Highlighted new wafer-level chip scale parts for implantable medical devices and surgical robots, high-sensitivity sensors for navigation, and nano power sensors for battery-powered devices at a trade show in Minneapolis.
Revenue and Sales: 4% sequential increase in revenue driven by distributor and nondefense sales, despite a decrease in defense sales. Gross margin decreased to 78% due to less profitable product mix.
Expenses and Tax: 7% decrease in total expenses year-over-year due to a 23% decrease in SG&A and a 3% increase in R&D expenses. Tax rate increased to 20% due to tax law changes, but advanced manufacturing tax credits are expected to offset this.
Production Expansion: Fixed asset purchases of $1.13 million for production equipment, with an additional $1-$1.5 million expected for further expansion.
Focus on High-Value Markets: R&D strategy targets high-value markets such as medical devices, electric vehicles, robotics, and AI-driven factories.
Trade Show Investments: Participation in trade shows to promote products and generate leads, particularly in the medical devices sector.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Economic Environment Uncertainties: The company acknowledges uncertainties related to the economic environments in the industries they serve, which could impact future sales and revenue.
Defense Sales Volatility: Defense sales decreased by 64% year-over-year due to the volatile nature of defense procurement cycles, which could impact revenue stability.
Gross Margin Decline: Gross margin decreased to 78% from 86% in the prior year quarter due to a less profitable product mix and strong distributor sales, which tend to have lower margins than direct sales.
Tax Law Changes: The company experienced a higher tax rate (20% compared to 17% in the prior year quarter) due to noncash impacts of tax law changes, which could affect net income.
R&D Revenue Decline: Contract R&D revenue decreased by 68% year-over-year, which could impact the company's ability to fund future innovations.
Production Expansion Costs: The company expects to spend an additional $1 million to $1.5 million on fixed assets in the next six months to complete production expansion, which could strain cash flow.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Tax Rate Projections: The company expects a full-year tax rate of between 16% and 17% for the current fiscal year, supported by advanced manufacturing investment tax credits of $700,000 to $1 million. For the next fiscal year, the effective tax rate is also projected to remain at approximately 16% to 17%.
Capital Expenditures: The company plans to spend an additional $1 million to $1.5 million on fixed assets in the last six months of the fiscal year to complete production expansion.
Production Expansion: The installation of new production equipment is expected to be completed by the end of the fiscal year, increasing capacity and capabilities, including in-house wafer-level chip scale packaging.
R&D and Product Development: The company plans to leverage new equipment to accelerate product development, focusing on high-value markets such as medical devices, electric and autonomous vehicles, advanced robotics, and AI-driven factories. Three new products were launched in the past quarter, and further growth is anticipated through continued innovation.
Market Trends and Sales Outlook: The company is optimistic about future sales growth, particularly in the medical devices market, supported by recent trade show participation and new product introductions tailored for miniaturization and reliability in medical applications.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Should we expect to see growth in revenues for the new equipment or just growth in capabilities?
A:The new equipment is intended to increase both capabilities and develop new products, fueling future growth.
Q:When should we see that future growth?
A:The company is already starting to see results from R&D and expansion plans, with strong growth in the core market in the past quarter.
Q:When will chip-level scale packaging ramp up?
A:The company has been sampling products for several quarters and expects it to be a significant growth driver going forward, potentially as soon as the current quarter in industrial markets.
Q:What are the advantages of chip-level scale packaging?
A:The parts are smaller, more precise, and less susceptible to supply chain risks. Additionally, in-house production reduces costs and mitigates tariff uncertainties.
Q:Does wafer-scale packaging allow for a fully domestic supply chain?
A:The company has a mostly domestic supply chain but still relies on some overseas materials. Wafer-level chip scale packaging will bring key elements of the supply chain in-house.
Q:What does the company provide in the medical device market, specifically for hearing aids and cardiac rhythm management?
A:The company enables secure communication between devices and the outside world, with small, low-power, and reliable parts. For hearing aids, they provide solutions for detecting handset proximity. For cardiac rhythm management, they offer unique capabilities for implanted medical devices.
Q:Is the company applicable in data center applications with the move to 800-volt DC?
A:Yes, the company has high isolation voltage ratings suitable for data center applications and is targeting this market through direct outreach and specialized distributors.
Q:Has the company achieved any design wins in the eVTOL market?
A:The company targets Tier 1 and Tier 2 suppliers in the eVTOL market and has several design wins in automotive-adjacent markets like charging stations, trucks, and trains.
Q:Is the company targeting the gaming market with its TMR sensors?
A:The company has explored the gaming market but focuses on more demanding markets like robotics, industrial IoT, and medical. They demonstrated their sensors' superior speed and precision compared to alternatives.
Q:Did the PUF market recover in the quarter?
A:The company discussed sequential growth but not year-over-year growth. The PUF market is volatile and not a key part of the growth strategy.
Q:What is the company's progress in replacing rare earth magnets with high-sensitivity sensors?
A:The company has promoted rare earth-free magnets and high-sensitivity sensors, which have translated into sales, though it's unclear how many replace rare earth magnets.
Q:What is the company's space situation for future expansion?
A:The company has renewed its lease and has contingency plans to move certain groups to a different building if needed for expansion.
Q:Is the company targeting the Hall Effect sensor market?
A:The company targets the high-end Hall Effect sensor market but does not compete with commodity switches. They focus on markets requiring high performance.
Q:Are NVE parts used in robotic applications like Amazon's distribution centers?
A:Yes, NVE parts are suitable for industrial robots, smart factories, and warehouses requiring precision and speed.
Q:Will the company break out product sales by segments in reports?
A:The company does not plan to formally break out segments in reports but provides additional context during calls.
Q:What is the percentage of distributor sales versus direct sales?
A:The company did not provide a percentage breakdown but stated both are important, with direct sales targeting large customers and distributor sales being more distributed.
Q:What is the company's approach to contract R&D?
A:Contract R&D is mostly defense-related and helps build the intellectual property portfolio. It is not a direct growth driver but facilitates future sales.
Q:Does the government shutdown affect contract R&D?
A:The shutdown is not expected to significantly impact contract R&D, as the cycles are longer-term.
Q:What is the company's outlook for revenue growth in the current quarter?
A:The company is optimistic about growth in the current quarter due to a strong pipeline and industry recovery.
Q:Why did interest income increase despite declining cash?
A:The increase in interest income is due to new security purchases at higher interest rates, while cash decreased due to higher cash dividends.
Q:Review of Unclear Management Responses
A:Management avoided providing specific timelines or detailed breakdowns for certain questions, such as the exact percentage of distributor versus direct sales and the precise impact of rare earth-free magnet sales. Additionally, they were vague about the specifics of their customers' applications in the medical device market and the exact correlation between contract R&D and future product revenue growth.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Advanced Technology
Contract RD
Eames Vice
President Advanced
RD increase
SGA
Vice President
asset
bill
cash
cluster production
conversion
decrease defense
decrease tax
deduction
defense sale
equipment product
factory
income share
increase RD
increase product
investment tax
law change
manufacturing investment
month
nondefense sale
payment
product RD
sale Contract
sale decrease
scale packaging
tax credit
tax law
tax rate
NVEC Transcript
NVE Corporation (NVEC) Q4 2026 Earnings Call Transcript
Unknown5-6
The earnings call lacks substantial information on key financial metrics, risks, and returns, making it difficult to gauge a strong market reaction. The strategic initiatives mentioned, such as sustainability, have limited immediate impact on stock price. Without clear guidance or significant updates, the stock is likely to remain stable, resulting in a neutral prediction.
NVE Corporation (NVEC) Q3 2026 Earnings Call Transcript
Positive1-21
The earnings call reveals several positive aspects: ongoing production expansion, new product launches, and optimistic sales outlook in medical devices. The Q&A section highlights increased distributor sales, effective marketing efforts, and promising partnerships like Abbott. While there are some uncertainties, such as the nascent MagNav technology and lack of specific details in defense sector recovery, the overall sentiment is positive due to growth in key markets and strategic investments. The absence of negative financial surprises or guidance cuts further supports a positive stock movement prediction.
NVE Corporation (NVEC) Q2 2026 Earnings Call Transcript
Positive10-22
The earnings call shows promising signs of future growth with strong R&D results and expansion plans, especially in core markets. The company's focus on innovative products like wafer-level chip scale sensors and advanced magnetic switch sensors is expected to drive sales. While some responses were vague, the overall sentiment from the Q&A indicates optimism, particularly with upcoming growth drivers and industry recovery. The anticipation of significant cash flow savings and a strong pipeline further supports a positive outlook for stock price movement.
NVE Corporation (NVEC) Q1 2026 Earnings Conference Call Transcript
Positive7-23
The earnings call highlights strong financial performance with comprehensive income and positive operating cash flow, despite lower margins. The Q&A reveals growth expectations in the PUF business and potential in replacing rare earth metals. Strategic investments in wafer-scale packaging and patents on SOT RAM are promising. Although management was vague on certain reporting aspects, the overall sentiment is positive with anticipated growth in military orders and new market expansions, supporting a positive stock price movement.
NVEC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
